Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 247

    1.

    Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality.

    Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G.

    Diabetes Care. 2003 Oct;26(10):2883-9.PMID: 14514596 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.

    Piemonti L, Calori G, Lattuada G, Mercalli A, Ragogna F, Garancini MP, Ruotolo G, Luzi L, Perseghin G.

    Diabetes Care. 2009 Nov;32(11):2105-10. Epub 2009 Jul 29.PMID: 19641159 [PubMed - in process]Related articles

    3.

    The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm.

    Panarotto D, Ardilouze JL, Tessier D, Maheux P.

    Metabolism. 2000 Aug;49(8):1055-62.PMID: 10954026 [PubMed - indexed for MEDLINE]Related articles

    4.

    Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.

    Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D.

    Int J Obes Relat Metab Disord. 1999 Apr;23(4):355-60.PMID: 10340812 [PubMed - indexed for MEDLINE]Related articles

    5.

    Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men.

    Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB.

    Atherosclerosis. 2001 Aug;157(2):495-503.PMID: 11472752 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

    Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW.

    JAMA. 2000 Jan 12;283(2):221-8.PMID: 10634338 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.

    Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG.

    J Clin Endocrinol Metab. 1999 Jan;84(1):272-8.PMID: 9920095 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes.

    Bulló M, Garcia-Lorda P, Salas-Salvadó J.

    Eur J Endocrinol. 2002 Mar;146(3):325-31.PMID: 11888838 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The pituitary-gonadal axis and health in elderly men: a study of men born in 1913.

    Tibblin G, Adlerberth A, Lindstedt G, Björntorp P.

    Diabetes. 1996 Nov;45(11):1605-9.PMID: 8866567 [PubMed - indexed for MEDLINE]Related articles

    11.

    Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study.

    Brennan AM, Li TY, Kelesidis I, Gavrila A, Hu FB, Mantzoros CS.

    Diabetologia. 2007 Jun;50(6):1178-85. Epub 2007 Mar 20.PMID: 17372717 [PubMed - indexed for MEDLINE]Related articles

    12.

    Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

    Nakamura K, Yamagishi S, Adachi H, Kurita-Nakamura Y, Matsui T, Yoshida T, Imaizumi T.

    Mol Med. 2007 Mar-Apr;13(3-4):185-9.PMID: 17592553 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

    Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE.

    Circulation. 2007 Jul 10;116(2):151-7. Epub 2007 Jun 18.PMID: 17576864 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.

    Marita AR, Sarkar JA, Rane S.

    Mol Cell Biochem. 2005 Jul;275(1-2):143-51.PMID: 16335794 [PubMed - indexed for MEDLINE]Related articles

    16.

    Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.

    Chacón MR, Fernández-Real JM, Richart C, Megía A, Gómez JM, Miranda M, Caubet E, Pastor R, Masdevall C, Vilarrasa N, Ricard W, Vendrell J.

    Obesity (Silver Spring). 2007 Mar;15(3):664-72.PMID: 17372317 [PubMed - indexed for MEDLINE]Related articles

    17.

    Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men.

    Chu NF, Spiegelman D, Rifai N, Hotamisligil GS, Rimm EB.

    Int J Obes Relat Metab Disord. 2000 Sep;24(9):1085-92.PMID: 11033975 [PubMed - indexed for MEDLINE]Related articles

    18.

    Plasma TNF-R1 and insulin concentrations in relation to leptin levels among normal and overweight children.

    Chu NF, Shen MH, Wu DM, Shieh SM.

    Clin Biochem. 2002 Jun;35(4):287-92.PMID: 12135690 [PubMed - indexed for MEDLINE]Related articles

    19.

    Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.

    Ohya M, Taniguchi A, Fukushima M, Nakai Y, Kawasaki Y, Nagasaka S, Kuroe A, Taki Y, Yoshii S, Hosokawa M, Inagaki N, Seino Y.

    Metabolism. 2005 Oct;54(10):1297-301.PMID: 16154427 [PubMed - indexed for MEDLINE]Related articles

    20.

    Leptin: a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes.

    Wallander M, Söderberg S, Norhammar A.

    Diabet Med. 2008 Aug;25(8):949-55.PMID: 18959608 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data